×ðÁú¿­Ê±

EN
EN
  • ÓªÒµ×Éѯ

    Öйú£º

    Email: marketing@medicilon.com.cn

    ÓªÒµ×ÉѯרÏߣº400-780-8018

    £¨½öÏÞЧÀÍ×Éѯ £¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©

    ´¨É³×ܲ¿µç»°: +86 (21) 5859-1500

    ÍâÑó£º

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

ÔÚÏßÁôÑÔ¡Á
µã»÷Çл»
News information
ÐÂÎÅ×ÊѶ

ÃÀÑÐ| dzÎöICHÖ¸µ¼Ô­ÔòQ3C¼°Î´Êº²¼²ÐÁôÈܼÁÏÞ¶ÈÖÆ¶©ÒªÁì

2023-11-10
|
»á¼ûÁ¿£º

dzÎöICHÖ¸µ¼Ô­ÔòQ3C¼°Î´Êº²¼²ÐÁôÈܼÁÏÞ¶ÈÖÆ¶©ÒªÁì.jpg

ICHÖ¸µ¼Ô­ÔòQ3CÖ¼ÔÚÏÈÈÝÒ©ÎïÖвÐÁôÈܼÁÔÚ°ü¹ÜÈËÌåÇå¾²Ìõ¼þϵĿɽÓÊÜÁ¿ £¬½¨ÒéʹÓõͶ¾µÄÈܼÁ £¬Ìá³öһЩ²ÐÁôÈܼÁ¶¾ÀíѧÉϵĿɽÓÊÜˮƽ¡£

²ÐÁôÈܼÁ½ç˵ΪÔÚÖÊÁÏÒ©»ò¸¨ÁϵÄÉú²úÖÐÒÔ¼°ÖƼÁÖÆ±¸Àú³ÌÖÐʹÓûò±¬·¢µÄÓлú»Ó·¢ÐÔ»¯ºÏÎï £¬ÓÉÓÚ²ÐÁôÈܼÁûÓÐÖÎÁÆÒæ´¦ £¬¹ÊÓ¦¾¡¿ÉÄܳýÈ¥ÒÔÇкÏÏà¹ØÖÊÁ¿ÒªÇó¡£

ͼ1-ICH-Q3C(R8)-ÔÓÖÊ£º²ÐÁôÈܼÁµÄÖ¸µ¼Ô­Ôò.jpg

ͼ1 ICH Q3C(R8) ÔÓÖÊ£º²ÐÁôÈܼÁµÄÖ¸µ¼Ô­Ôò

ICHÖ¸µ¼Ô­ÔòQ3CÊÊÓÃÓÚËùÓмÁÐͺ͸øÒ©Í¾¾¶ £¬ÆäÖÐÒ©ÎïÔÚ¶ÌÆÚʹÓûò¾Ö²¿Ê¹ÓÃʱ £¬»¹ÔÊÐí±£´æ¸ü¸ßµÄ²ÐÁôÈܼÁˮƽ £¬ÐèÒª×¢ÖØµÄÊǸÃÖ¸µ¼Ô­Ôò²»ÊÊÓÃÓÚÁÙ´²Ñо¿¿ª·¢½×¶ÎËùʹÓÃÐÂÖÊÁÏÒ©¡¢¸¨ÁϺÍÖÆ¼Á £¬Ò²²»ÊÊÓÃÓÚÒÑÉÏÊеÄÖÆ¼Á¡£

¹ØÓÚ¡°Ò©ÎïÔÓÖÊ"µÄÊÓÆµÍƼö

²ÐÁôÈܼÁ·ÖΪIÀàÈܼÁ£¨ÒÑÖªµÄÈËÌåÖ°©Îï £¬Ç¿ÒÉËÆÈËÌåÖ°©Îï £¬ÒÔ¼°ÇéÐÎΣº¦Îï £¬Ó¦×èֹʹÓã©¡¢IIÀàÈܼÁ£¨·ÇÒÅ´«¶¾ÐÔ¶¯ÎïÖ°©ÎïÖÊ £¬»ò¿ÉÄܵ¼ÖÂÆäËû²»¿ÉÄæ¶¾ÐÔÈçÉñ¾­¶¾ÐÔ»òÖ»ûÐÔÈܼÁ £¬¿ÉÄÜÓÐÆäËûÑÏÖØµ«¿ÉÄæµÄ¶¾ÐÔµÄÈܼÁ £¬Ó¦ÏÞÖÆÊ¹Óã©¡¢IIIÀàÈܼÁ£¨¶ÔÈËÌåµÍDZÔÚ¶¾ÐÔµÄÈܼÁ £¬ÒÅ´«¶¾ÐÔ³ÊÒõÐÔ £¬ÎÞÐëÖÆ¶©»ùÓÚ¿µ½¡µÄ̻¶ÏÞ¶È £¬ÊǵÍDZÔÚ¶¾ÐÔÈܼÁ£©ÒÔ¼°Ã»ÓÐ×ã¹»¶¾ÀíѧÊý¾ÝµÄÈܼÁ £¬ÔÚ×ö²ÐÁôÈܼÁ¼ì²âʱ £¬ÐèÒªÅÌËã±ÈÕÕÆ·³ÆÑùÁ¿µÈ £¬¿ÉÒÔÆ¾Ö¤ÏÂÁбí¸ñ¾ÙÐÐÅÌËã £¬ÏÂÁбí¸ñΪ×îвÐÁôÈܼÁÏ޶ȵĻã×Ü¡£

IÀàÈܼÁÏ޶ȼ°Æä¹Ø×¢µã.jpg

IIÀàÈܼÁ-PDEÖµ¼°ÆäÏÞ¶È.jpg

IIIÀàÈܼÁ¼°ÆäÏÞ¶È.jpg

ÏÖÔÚʵÑéµÄÊÇICH Q3C£¨R8£©°æ±¾ £¬ÔÚ֮ǰ°æ±¾¾ÙÐÐÁËÒÔϸüУº

1. ÒÒ¶þ´¼µÄPDEÓÉ3.1mg/day¸ÄΪ6.2mg/day £¬Òò´ËÏÞ¶ÈÓÉ310ppm¸ÄΪ620ppm¡£

2. ½«Êå¶¡´¼(TBA)ÐÂÔöΪ¶þÀàÈܼÁ £¬PDEΪ35mg/Ìì, ÏÞ¶ÈΪ3500ppm¡£

3. ½«CPME (»·Îì»ù¼×ÃÑ)ÐÂÔöΪ¶þÀàÈܼÁ £¬PDEΪ15 mg/Ìì £¬ÏÞ¶ÈΪ1500ppm¡£

4. ½«2-MTHF(2¼×»ùËÄÇâß»à«)ÐÂÔöΪ3ÀàÈܼÁ £¬PDEΪ50mg/Ìì¡£

³ýÁËÒÔÉÏÈýÀàÈܼÁÍâ £¬»¹±£´æÒ»Ð©Ã»ÓÐ×ã¹»¶¾ÀíѧÊý¾ÝµÄÈܼÁ £¬¹ÊûÓÐPDEÖµ £¬ÀýÈ磺1.1-¶þÒÒÑõ»ù±ûÍé¡¢¼×»ùÒì±û»ùͪ¡¢1.1-¶þ¼×Ñõ»ù¼×Íé¡¢¼×»ùËÄÇâ߻ૡ¢2.2-¶þ¼×Ñõ»ù±ûÍ顢ʯÓÍÃÑ¡¢ÒìÐÁÍé¡¢ÈýÂÈÒÒËá¡¢Òì±ûÃÑ¡¢Èý·úÒÒËáµÈ £¬ÕâЩ²ÐÁôÈܼÁµÄÏÞ¶ÈÐèҪʹÓÿÆÑ§ÎÄÏ׺Ͷ¾ÀíѧÊý¾ÝÀ´Öƶ©¡£

ÖðÈÕÔÊÐí̻¶Á¿(PDE)½ç˵ΪҩѧÉϿɽÓÊܵIJÐÁôÈܼÁÉãÈëÁ¿ £¬ÊÇÓÉ´ó´ó¶¼Ïà¹Ø¶¯ÎïÑо¿ÖеÄδÊӲ쵽×÷ÓÃˮƽ(NOEL)»òÊӲ쵽×÷ÓõÄ×îµÍˮƽ(LOEL)µÃ³öµÄ £¬ÓÐÁËÕâ¸öÊý¾Ý¼´¿É¾ÙÐвÐÁôÈܼÁµÄÏÞ¶ÈÅÌËã¡£

PDEµÄÅÌË㹫ʽΪ£º

PDEµÄÅÌË㹫ʽ.jpg

Óɹ«Ê½¿ÉÖª £¬NOELÊÇÅÌËã»ñµÃPDEµÄÒªº¦ £¬Í¨¹ýһЩ¶¾ÀíÑо¿Êý¾Ý¿ÉÒÔ»ñµÃÏà¹ØÐ§¹û £¬ÒÔÊDzÐÁôÈܼÁµÄ¿ØÖÆÕ½ÂÔÊ×Ñ¡NOELµÄÏà¹ØÊý¾Ý £¬Æ¾Ö¤ICHµÄÏà¹ØÄÚÈÝ £¬Ò²¿ÉÒÔʹÓÃLOELÀ´ÅÌËãPDE £¬¿ÉÊÇҪƾ֤×÷ÓõÄÑÏÖØË®Æ½ÔÚÅÌËãʱѡÔñºÏÊʵÄF5¡£

ÓÐʱÅÌÎÊÏà¹ØÊý¾Ý»¹»á²éµ½NOAEL(No Observed Adverse Effect Level)-δÊӲ쵽Óк¦×÷ÓÃˮƽ £¬Q3CÏÞ¶ÈÖÆ¶©ÒªÁìµÄ²Î¿¼ÎÄÏ×WHOÇéÐοµ½¡Ö¸ÄÏ170ÖÐTDI£¨Tolerable Daily Intake£©-ÖðÈÕÔÊÐíÉãÈëÁ¿ÊÇʹÓøÃÊýÖµÅÌËã»ñµÃ £¬²¢ÇÒÔÚICH Q3DÖ¸µ¼Ô­ÔòÅÌËãÔªËØÔÓÖʵÄPDEʱҲÃ÷È·Ö¸³ö¿ÉÒÔʹÓøÃÊýÖµ¾ÙÐÐÅÌËã £¬¹ØÓÚËûÃǵÄÇø±ð¼òÆÓÀ´Ëµ £¬NOELÏ൱ÓÚδ¼ì³ö £¬LOELÏ൱ÓÚ¼ì³öÏÞÒÔϵÄ×î´ó×Ú £¬NOAELÏ൱ÓÚ¶¨Á¿ÏÞÒÔϵÄ×î´ó×Ú £¬¿ÉÊÇNOELºÍNOAELÖ®¼äµÄ½çÏß½ÏΪģºý £¬ÔÚ¾ÙÐÐÊʵ±µÄÆÀ¹ÀºóÒ²¿ÉÒÔʹÓøÃÊýÖµ¾ÙÐÐPDEµÄÅÌËã £¬¿ÉÊÇ £¬½ÓÄɲî±ðÊý¾ÝÅÌËãPDEʱӦѡÔñ²î±ðµÄF5¾ÙÐÐУÕý¡£

ÓÐЩÏÈÉú»áÑ¡ÓÃLD50¾ÙÐÐÅÌËã £¬Ê¹ÓÃNOEL=LD50¡Á50/2000£¨Ô´×ÔÅ·ÃËÖÊÁÏҩίԱ»áÐû²¼µÄ¡¶ÖÊÁÏÒ©¹¤³§ÖÐÇå½àÑéÖ¤Ö¸ÄÏ¡· £¬2000ΪÂÄÀú³£Êý£©¾ÙÐÐÅÌËã»ñµÃPDE £¬×ÅÊÊÓô˹«Ê½Ó¦Óñ£´æÒ»¶¨¾ÖÏÞÐÔ £¬PDEÕë¶ÔµÄÊÇÆð×÷Óà £¬¿ÉÒÔÒÔΪÊÇÒ»ÖÖÓÐÓÃÐÔ £¬¶øLD50ÊÇÒ»ÖÖ¶¾ÐÔ £¬ÊôÓÚÇå¾²ÐÔÁìÓò £¬¶þÕßûÓÐÒ»¶¨ÁªÏµ¡£

ͼ2£º²»½¨ÒéʹÓõÄÏÞ¶ÈÖÆ¶©·½·¨.jpg

ͼ2£º²»½¨ÒéʹÓõÄÏÞ¶ÈÖÆ¶©·½·¨

ÔÚÇå½àÑéÖ¤Ö¸ÄÏ2021°æÖÐÒ²Ìáµ½ÁË £¬Ç¿ÁÒ½¨ÒéÏÞÖÆÊ¹ÓÃLD50×÷ΪÆô¶¯µã £¬ÓÉÓÚ¹ØÓÚºã¾ÃÓ°ÏìµÄÕ¹ÍûÊDz»¿ÉÐÅÈεÄ¡£

ͼ3-Ô´×Ô£ºAPICÇå½àÑéÖ¤Ö¸ÄÏ2021°æ.jpg

ͼ3 Ô´×Ô£ºAPICÇå½àÑéÖ¤Ö¸ÄÏ2021°æ

ͬʱLD50Ò²¾ßÓÐÐí¶à¾ÖÏÞÐÔ£º

1¡¢LD50ÖµÌṩµÄÓÐÓÃÐÅÏ¢½ÏΪÓÐÏÞ¡ £»¯Ñ§ÎïÖʵĵ¥´Î´ó¼ÁÁ¿¼±ÐÔ¶¾ÐÔ £¬Ê¹Ðí¶à¶¯ÎïËÀÓÚÖÐÊàÉñ¾­ÏµÍ³¼°ÐÄѪ¹Ü¹¦Ð§Õϰ­ £¬²»¿ÉºÜºÃµÄÏÔʾ³öÆä¶¾×÷ÓÃÌØÕ÷¡£

2¡¢LD50Öµ²»ÎȹÌ £¬ÊܶàÖÖÒòËØÓ°Ïì¡£1977ÄêÅ·ÖÞÅäºÏÌåÍøÂçµ½µÄ80¸öʵÑéÊÒ¶Ô5ÖÖ»¯Ñ§ÎïÖʵÄLD50Öµ £¬Ð§¹ûÄÜÏà²î2~8±¶¡£

3¡¢¼±ÐÔ¶¾ÐÔʵÑéËùÓüÁÁ¿ºÍÁÙ´²ÈËÓüÁÁ¿²î±ð½Ï´ó £¬²»¿ÉÓü±ÐÔ¶¾ÐÔʵÑéÀ´Öƶ©È˶àÁÙ´²¼ÆÁ¿¡£

4¡¢È˺Ͷ¯Îï¶ÔÒ©ÎïÃô¸ÐÐÔ²î±ð½Ï´ó¡£ÒÔ°¢ÍÐÆ·ÎªÀý £¬Ð¡ÊóµÄLD50ÖµÊÇÈ˵ÄÖÂËÀÁ¿µÄ250±¶¡£

»ùÓÚÒÔÉÏÖÖÖÖÔµ¹ÊÔ­ÓÉ £¬²»½¨ÒéʹÓÃLD50Öµ¾ÙÐÐPDEµÄÅÌËã £¬ÔÚÓÐÆäËûÏà¹ØÑо¿µÄÇéÐÎÏ £¬½¨ÒéÓÅÏÈÑ¡ÓÃÆäËûµÄÊý¾Ý¡£¹ØÓÚδʺ²¼µÄ²ÐÁôÈܼÁ £¬Ê×ÏȽ¨ÒéÅÌÎÊ»òÕ¹ÍûÆä»ùÒò¶¾ÐÔ £¬ÈôÊÇÊÇ»ù¶¾ £¬ÄǾÍÊÇM7µÄÁìÓò £¬¿ÉÓÃTTC·¨µÈ¾ÙÐпØÖÆ £¬ÈôÊDz»ÊÇ»ù¶¾ £¬Ê×ÏȽ¨Òé½ÓÄÉNOELÅÌËãPDEÖµ £¬ÈôÊÇûÓÐÏà¹ØÊý¾Ý £¬¿ÉÒÔ²ÎÕÕICH Q3A(ÐÂÖÊÁÏÒ©ÖеÄÔÓÖÊ)»òÕ߽ṹÀàËÆÎï¾ÙÐпØÖÆ¡£

ͼ4-Ô´×Ô£ºICH-Q3C.jpg

ͼ4 Ô´×Ô£ºICH Q3C

ÕâÀï·ÖÏíһЩ¶¾ÀíÊý¾ÝÅÌÎʵÄÍøÖ·¹©¸÷È˲ο¼Ê¹Óà £¬ÔÚÅÌÎÊÏà¹Ø¶¾ÀíѧÊý¾Ýʱ £¬½¨ÒéÊ×Ñ¡¹Ù·½µÄÑо¿Êý¾Ý £¬Æä´ÎÑ¡ÔñʵÑéÉè¼Æ¼°Àú³ÌÇкÏGLP»òOECDÖ¸µ¼Ô­ÔòµÄʵÑé»ñµÃµÄ¶¾ÀíÊý¾Ý £¬ÒÔÉÏÁ½Ïî¶¼²»Öª×ã £¬Ñ¡ÔñÊý¾ÝÅû¶ÍêÕûµÄkey study»ñµÃµÄ¶¾ÀíÊý¾Ý¡£

Ïà¹ØÊý¾ÝÅÌÎÊÍøÕ¾ £¬ÊäÈëCASºÅ»òÕßÒ©ÎïÓ¢ÎÄÃû¾ÙÐÐÅÌÎÊ

ÊäÈëCASºÅ»òÕßÒ©ÎïÓ¢ÎÄÃû¾ÙÐÐÅÌÎÊ.jpg

ToxInfoÍøÕ¾ÅÌÎÊ£ºhttps://www.toxinfo.io

ToxInfoÍøÕ¾ÅÌÎÊ.jpg

ToxInfoÌṩÁ˶ÔÏÂÁÐÊý¾Ý¿âµÄÃâ·Ñ»á¼û¼ìË÷£º

HSDB¡¢ChemIDplus¡¢CTD¡¢CPID¡¢Haz-Map¡¢IRIS¡¢ITER¡¢CCRIS¡¢CPDB¡¢GENE-TOX¡£Í¨¹ýÊý¾Ý¿â»ñµÃTD50Êý¾Ýºó £¬¿ÉÒÔÆ¾Ö¤ÒÔÏÂÓγ̾ÙÐÐÅÌËã £¬»ñµÃ¸ÃÈܼÁµÄÏÞ¶È¡£

ÆäËûÊý¾Ý¿â£º

https://www.epa.gov/iris

https://ntp.niehs.nih.gov/µÈ

£¨×«¸å£ºÀîÄ« £»±àÉ󣺱ÏÔö£©

Ïà¹ØÐÂÎÅ
¡Á
ËÑË÷ÑéÖ¤
µã»÷Çл»
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿